THIORIDAZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thioridazine, and what generic alternatives are available?
Thioridazine is a drug marketed by Actavis Mid Atlantic, Alpharma Us Pharms, Ani Pharms, Epic Pharma Llc, Pharm Assoc, Sandoz, Wockhardt, Chartwell Rx, Heritage Pharma Avet, Mutual Pharm, Mylan, Par Pharm, Roxane, Sun Pharm Industries, Superpharm, Watson Labs, Watson Labs Teva, and West Ward. and is included in seventy-nine NDAs.
The generic ingredient in THIORIDAZINE is thioridazine hydrochloride. There are eighteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the thioridazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thioridazine
A generic version of THIORIDAZINE was approved as thioridazine hydrochloride by MYLAN on March 15th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for THIORIDAZINE?
- What are the global sales for THIORIDAZINE?
- What is Average Wholesale Price for THIORIDAZINE?
Summary for THIORIDAZINE
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 79 |
| Drug Prices: | Drug price information for THIORIDAZINE |
| DailyMed Link: | THIORIDAZINE at DailyMed |
Recent Clinical Trials for THIORIDAZINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Rambam Health Care Campus | Early Phase 1 |
| Rabin Medical Center | Early Phase 1 |
| Astellas Pharma Inc | Phase 4 |
Medical Subject Heading (MeSH) Categories for THIORIDAZINE
Anatomical Therapeutic Chemical (ATC) Classes for THIORIDAZINE
US Patents and Regulatory Information for THIORIDAZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 088284-001 | Aug 25, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 088004-001 | Nov 18, 1983 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mutual Pharm | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 087264-001 | Nov 18, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
